The Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) met on 11 September 2012 and discussed a range of topics including proposed new work to be undertaken by SaBTO on the risks associated with certain donors and organs for transplantation and on cellular therapies; developments relating to vCJD risk reduction measures and a review of the advice and recommendations published by SaBTO in the last year.
Agenda
Minutes
Papers
- update on methylene blue treated fresh frozen plasma
- the ACDP position statement on occurrence of vCJD and prevalence of infection in the UK population
- the extract from the Health Protection Agency health protection report: summary results of the 2nd national survey of abnormal prion prevalence in archived appendix specimens
- the most recent CJD figures for the UK
- update on the development of a transplant donor risk index
- cellular therapies
- update on proposed work relating to microbiological risks associated with stem cell therapy and ATMPs
- HTA abstract on addressing donor testing issues
- September 2012 update for SaBTO working group on MSM tissues and cells
- update on the use of CMV seronegative blood components
- update on advice on transplanting organs from donors with primary brain tumours
- September 2012 update on investigations of blood donor compliance
- schmallenberg virus cover sheet
- rapid risk assessment on schmallenberg virus
- update on the recruitment to vacancies on SaBTO
